TPU-29818-85363
1 vaccination
3 coded responses
15 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 176 / PA
- Registered
- 2021-12-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-14
Registered in v-safe
-
2021-12-14
Dose 1 — Pfizer-BioNTech
- 2021-12-14
-
2021-12-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-28
-
2022-01-04
Survey response — day 21, dose 1MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I acquired COVID-19MedDRA releases: 2024-11 · check-in free text available
-
2022-01-04
Report sent to call center — day 21, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-05
-
2022-01-05
Call successfulCompleted over the phone
- 2022-01-18
- 2022-01-25
- 2022-03-17
-
2022-06-16
Survey response — 6 months, dose 1MedDRA: Fatigue, Headache, Neuralgia — Feeling: Fair · Be unable to work or attend schoolFree text: Nerve pain, severe fatigue, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Survey response — 12 months, dose 1MedDRA: Fatigue, Myalgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Severe fatigue, muscle aches/painsMedDRA releases: 2024-11 · check-in free text available
-
2022-12-14
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-15
- 2022-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-14 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
VAERS report filed, before or during a call: 2
Free text
Release 10 — day 21, dose 1
Symptoms: I acquired COVID-19
Release 12 — 6 months, dose 1
Symptoms: Nerve pain, severe fatigue, headache
Release 12 — 12 months, dose 1
Symptoms: Severe fatigue, muscle aches/pains
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Neuralgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release